Stockscreener 앱 받기
12.46
25.82%
-4.395
전일 마감가:
$16.85
열려 있는:
$14.73
하루 거래량:
4.81M
Relative Volume:
6.42
시가총액:
$1.29B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
24.91
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
-25.10%
1개월 성능:
-36.13%
6개월 성능:
-49.82%
1년 성능:
-56.73%
1일 변동 폭
$11.60
$14.79
1주일 범위
$11.60
$17.54
52주 변동 폭
$11.60
$32.66
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
12.47 | 1.29B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
132.25 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.35 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.67 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.46 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.33 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra: Q1 Earnings Snapshot - CTPost
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Beats Estimates, Revenue Hits $382.7 Million - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Revenue Expectations - GuruFocus
Integra LifeSciences Reports First Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Reports Q1 In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Rep - GuruFocus
Stock Performance Spotlight: Integra Lifesciences Holdings Corp (IART) Ends the Day at 16.44, Up by 0.31 - DWinneX
Is Integra Lifesciences Holdings Corp (IART) a good investment opportunity? - uspostnews.com
The Future of Integra Lifesciences Holdings Corp: Analyzing IART - investchronicle.com
An Analysis of Integra Lifesciences Holdings Corp (IART)’s Potential Price Growth - knoxdaily.com
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation (NASDAQ: IART); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investig - GlobeNewswire
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Target Price at $22.71 - Defense World
Integra Lifesciences Holdings Corp (NASDAQ:IART) Price Forecast For The Next 12 Months Is Set At 86. - Marketing Sentinel
Notice to Long-Term Shareholders of Integra Lifesciences - GlobeNewswire
Integra Lifesciences Holdings Corp (IART) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
IART Stock Sees Surge of Approximately 1.12% in Last Five Days - knoxdaily.com
Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire
Post-Trade Analysis: Integra Lifesciences Holdings Corp (IART) Climbs 3.16, Closing at 15.67 - DWinneX
Integra LifeSciences stock hits 52-week low at $15.45 - Investing.com
JPMorgan Chase & Co. Purchases 113,061 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025 - Nasdaq
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Yahoo Finance
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Truist Adjusts Price Target for Integra LifeSciences (IART) Ahea - GuruFocus
Integra LifeSciences stock hits 52-week low at $16.76 - Investing.com
Integra LifeSciences stock hits 52-week low at $16.76 By Investing.com - Investing.com Canada
Attention Long-Term Shareholders of Axsome Therapeutics, - GlobeNewswire
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Sei Investments Co. - Defense World
Do Options Traders Know Something About Integra (IART) Stock We Don't? - Yahoo Finance
Norges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is - GlobeNewswire
Orion Portfolio Solutions LLC Invests $728,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning AS - Defense World
Raymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Argus upgrades Integra to Buy, says well-positioned for a turnaround - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Rating Increased to Buy at Argus - Defense World
Argus raises Integra LifeSciences stock rating to buy, sets $28 target By Investing.com - Investing.com South Africa
Argus raises Integra LifeSciences stock rating to buy, sets $28 target - Investing.com
ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT) - Morningstar
Pediatric Neurology Devices Market Worth, $5.8 Billion by 2031 | - openPR.com
Quantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART INVESTOR REMINDER: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Integra Lifesciences Holdings Corp 주식 (IART) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
9.38%
0.12%
자본화:
|
볼륨(24시간):